Kenyan Scientist Prof George Njoroge Co Leads Sh446 Million Cancer Detection Breakthrough

 

Professor George Njoroge, one of the lead researchers behind an award winning international project improving early detection and diagnosis of oesophageal cancer in Kenya.

Kenya continues to make global strides in medical research after renowned scientist Professor George Njoroge emerged as one of the key leaders behind a groundbreaking international cancer detection project valued at approximately Sh446 million. The Kenyan researcher worked alongside leading UK scientist Professor Robert Bristow in a major initiative aimed at transforming the early detection of oesophageal cancer, one of the deadliest and most overlooked cancers in East Africa.

Professor Njoroge, who serves as an investigator at Kenyatta University Teaching Referral and Research Hospital, has been at the forefront of efforts to improve cancer diagnosis in Kenya through innovation, research, and community centred healthcare approaches. The project has already attracted international recognition for its impact in addressing a disease that continues to claim thousands of lives due to late diagnosis and limited access to specialised medical care.

The partnership between Kenyan medical institutions and the University of Manchester introduced a new model that combines mobile cancer screening, training of healthcare workers, and public awareness campaigns. The programme was designed to reach vulnerable and underserved communities where access to specialised cancer services remains limited.

Through the initiative, hundreds of clinicians and community health workers across several counties have received specialised training to help identify symptoms earlier and guide patients toward timely treatment. Mobile endoscopy units were also introduced to expand screening services beyond major hospitals and into communities where healthcare access is often a challenge.

The programme has already screened thousands of people across counties including Meru, Kisii, Nyeri, Nakuru, and Kiambu. Health experts involved in the project say the approach is helping detect oesophageal cancer earlier, greatly improving treatment outcomes and survival chances for patients.

According to Professor Njoroge, the project was developed not only to strengthen early diagnosis but also to tackle major barriers that prevent many Kenyans from seeking cancer screening. These include fear, stigma, misinformation, poverty, and the lack of nearby specialised facilities.

Researchers involved in the programme believe the project could become a model for cancer prevention and early detection across Africa. Beyond screening, the initiative is also helping scientists better understand the environmental and biological factors contributing to the high rates of oesophageal cancer in East Africa.

The collaboration has further strengthened research ties between Kenya and the United Kingdom while opening opportunities for knowledge sharing, medical innovation, and advanced healthcare training. Medical experts say the findings from the project could influence future cancer screening systems in both countries.

The recognition of Professor George Njoroge marks another proud moment for Kenya on the global stage, highlighting the growing contribution of Kenyan scientists in solving major health challenges through research and innovation.